Xiaobin Ma
Impact in
- Physiology top 5%
- Adenosine and Purinergic Signaling
-
- Cancer-related molecular mechanisms research
Papers in
-
- Breast Cancer Treatment Studies 6
-
- RNA modifications and cancer 2
- Co-authors
- Huafeng Kang (16 shared papers)Min Qian (2 shared papers)Bing Du (2 shared papers)Shuai Lin (7 shared papers)Zheng Wang (1 shared paper)Binghe Tan (1 shared paper)Chunyan Zhang (2 shared papers)Mingyao Liu (1 shared paper)
- Journals
- Advanced Science (2 papers)Journal of Cancer Research and Clinical Oncology (2 papers)Frontiers in Genetics (1 paper)Advanced Healthcare Materials (1 paper)The Journal of Immunology (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaobin Ma
28 papers receiving 394 citations
Peers
Comparison fields: 5 of 80
- Physiology 62
- Cancer Research 45
- Immunology 49
- Infectious Diseases 37
- Molecular Biology 139
Countries citing papers authored by Xiaobin Ma
This map shows the geographic impact of Xiaobin Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Ma more than expected).
Fields of papers citing papers by Xiaobin Ma
This network shows the impact of papers produced by Xiaobin Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Ma. The network helps show where Xiaobin Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 58 | |
| 2 | 2016 | 50 | |
| 3 | 2019 | 38 | |
| 4 | 2016 | 38 | |
| 5 | 2022 | 24 | |
| 6 | 2021 | 18 | |
| 7 | 2019 | 18 | |
| 8 | 2022 | 16 | |
| 9 | 2022 | 15 | |
| 10 | 2023 | 14 | |
| 11 | 2023 | 14 | |
| 12 | 2015 | 12 | |
| 13 | 2017 | 9 | |
| 14 | [Compounds from fraction with cardiovascular activity of Chrysanthemum indicum]. | 2012 | 9 |
| 15 | The role of ATP8A1 in non-small cell lung cancer. | 2017 | 9 |
| 16 | 2023 | 8 | |
| 17 | 2024 | 8 | |
| 18 | 2016 | 8 | |
| 19 | 2021 | 5 | |
| 20 | [The effect of Hongjingtian (Gadol) injection on cardiac hemodynamics and myocardial oxygen consumption of dogs]. | 2005 | 5 |
About Xiaobin Ma
Xiaobin Ma is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Biomaterials, having authored 32 papers that have together received 397 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Nanoparticle-Based Drug Delivery (3 papers), Nanoplatforms for cancer theranostics (3 papers), Ferroptosis and cancer prognosis (2 papers), Adenosine and Purinergic Signaling (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Pharmacological Effects of Natural Compounds (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Physiology (62 citations), Cancer Research (45 citations), Immunology (49 citations), Infectious Diseases (37 citations) and Molecular Biology (139 citations). Xiaobin Ma has collaborated with scholars based in China and United States. Frequent co-authors include Huafeng Kang, Min Qian, Bing Du, Shuai Lin, Zheng Wang, Binghe Tan, Chunyan Zhang, Mingyao Liu, Ling Zhao and Na Zhang. Their work appears in journals such as Advanced Science, Journal of Cancer Research and Clinical Oncology, Frontiers in Genetics, Advanced Healthcare Materials and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.